https://clinicaltrials.gov/ct2/show/NCT03615040?type=Intr&cond=COPD&phase=01234&lupd_s=10%2F19%2F2018&lupd_d=14&sort=nwst Anti-ST2 (MSTT1041A) in COPD (COPD-ST2OP) Condition : COPD Exacerbation Interventions : Drug: MSTT1041A; Drug: Placebo Sponsors : University of Leicester; Biomedical Research Centre- Respiratory (Glenfield Hospital, Leicester UK); Leicester Clinical Trials Unit; Genentech, Inc. Recruiting NCT03615040 Fri, 03 Aug 2018 12:00:00 EDT
